Accuray reported $53.42M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Accuray USD 53.42M 8.45M Dec/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Artivion USD 445.58M 4.88M Jun/2026
AtriCure USD 516.43M 24.74M Jun/2026
Boston Scientific USD 24.93B 934M Jun/2026
Edwards Lifesciences USD 10.62B 290.5M Jun/2026
Inogen USD 197.18M 2.32M Sep/2025
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Orthofix International USD 429.18M 6.01M Jun/2026
Tandem Diabetes Care USD 130.39M 2.02M Jun/2026
Trinity Biotech USD -71.98M 17.26M Dec/2025